Redeye provides an update following Corline's release of a financial forecast for 2026 and guidance for 2027, together with a clarification of its long-term growth potential. The guidance makes it clear that Kardium is rolling out the Globe system in a stepwise manner and that both our and the market's expectations for the pace of the ramp-up have been too optimistic. We lower our short-term estimates considerably, while our long-term estimates remain broadly unchanged and in line with the company's own expectations. However, our fair value continues to see clear upside in the share.
LÄS MER
